Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Abstract

BACKGROUND There are few sex-specific outcome data in heart failure with preserved ejection fraction. METHODS AND RESULTS We assessed sex differences in baseline characteristics and outcomes among 4128 patients with heart failure with preserved ejection fraction in the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Women… (More)

Topics

6 Figures and Tables

Slides referencing similar topics